The most significant deals in MMR included large single-plot acquisitions of 50 acres or more in emerging micro-markets like ...

India has "absolutely no interest" in undermining the US dollar, and its fellow members of the Brics grouping of emerging economies have not formed a unified position on a proposed alternative payment ...

But the big picture shows another interesting trend -- regional parties can’t be ignored and enjoy significant political space in India. Kerala maintained its reputation as a state that swings ...

The price of commonly used diabetes drug empagliflozin has been slashed by almost one-tenth, with the entry of its generic ...

Stagflation, a macroeconomic concept, is making a lot of sense, especially for India, which is experiencing severe ...

Donald Trump has been upending the world order since his return to the White House in January. In the second instalment of a three-part series on the implications of Trump's foreign policy, we look at ...

WRI India paper says scheme increased women bus user’s average travel distance from 7.92 km to 10.52 km, enabling them to ...

The Economic Offences Wing of the Mumbai Police investigating the case says that Hiren and his wife Gauri Bhanu were beneficiaries of the funds misappropriated by the main accused ...

Empagliflozin is an SGLT-2 (Sodium-Glucose Co-Transporter-2) inhibitor indicted for use in the treatment of type-2 diabetes mellitus.

Alkem Laboratories announced the launch of generic empagliflozin and its combinations in India under the brand name Empanorm at prices that are approximately 80% lower than the innovator products.

Alkem Laboratories Ltd announced the launch of generic empagliflozin and its combinations in India under the brand name “Empanorm” at prices that are approximately 80% lower than the innovator ...